1. Home
  2. RVMD vs EXLS Comparison

RVMD vs EXLS Comparison

Compare RVMD & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • EXLS
  • Stock Information
  • Founded
  • RVMD 2014
  • EXLS 1999
  • Country
  • RVMD United States
  • EXLS United States
  • Employees
  • RVMD N/A
  • EXLS N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • EXLS Business Services
  • Sector
  • RVMD Health Care
  • EXLS Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • EXLS Nasdaq
  • Market Cap
  • RVMD 7.5B
  • EXLS 7.1B
  • IPO Year
  • RVMD 2020
  • EXLS 2006
  • Fundamental
  • Price
  • RVMD $43.81
  • EXLS $42.57
  • Analyst Decision
  • RVMD Strong Buy
  • EXLS Strong Buy
  • Analyst Count
  • RVMD 16
  • EXLS 6
  • Target Price
  • RVMD $73.56
  • EXLS $51.33
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • EXLS 1.2M
  • Earning Date
  • RVMD 11-05-2025
  • EXLS 10-28-2025
  • Dividend Yield
  • RVMD N/A
  • EXLS N/A
  • EPS Growth
  • RVMD N/A
  • EXLS 34.45
  • EPS
  • RVMD N/A
  • EXLS 1.45
  • Revenue
  • RVMD N/A
  • EXLS $1,968,978,000.00
  • Revenue This Year
  • RVMD N/A
  • EXLS $14.72
  • Revenue Next Year
  • RVMD $454.11
  • EXLS $11.47
  • P/E Ratio
  • RVMD N/A
  • EXLS $29.29
  • Revenue Growth
  • RVMD N/A
  • EXLS 15.15
  • 52 Week Low
  • RVMD $29.17
  • EXLS $35.76
  • 52 Week High
  • RVMD $62.40
  • EXLS $52.43
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 63.22
  • EXLS 44.31
  • Support Level
  • RVMD $39.73
  • EXLS $42.18
  • Resistance Level
  • RVMD $47.21
  • EXLS $44.22
  • Average True Range (ATR)
  • RVMD 1.81
  • EXLS 0.91
  • MACD
  • RVMD 0.57
  • EXLS -0.17
  • Stochastic Oscillator
  • RVMD 64.77
  • EXLS 13.45

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: